8 Einträge gefunden

1. PSMA-ligand PET for early castration-resistant prostate cancer: a retrospective single-center study

   1. Weber, Manuel
   2. Kurek, Claudia Ewa
   3. Barbato, Francesco
   4. Eiber, Matthias
   5. Maurer, Tobias
   6. Nader, Michael
   7. Hadaschik, Boris

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP

   1. Folprecht, Gunnar
   2. Trautmann, Karolin
   3. Stein, Alexander
   4. Huebner, Gerdt
   5. Stahl, Michael
   6. Kasper, Stefan
   7. Kretzschmar, Albrecht

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study

   1. Grünwald, Viktor
   2. Karch, Annika
   3. Schuler, Markus
   4. Schöffski, Patrick
   5. Kopp, Hans-Georg
   6. Bauer, Sebastian
   7. Kasper, Bernd

   2020 - Forschungsinformationssystem des UKE
4. Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care-Registry data from an outcomes research project of the German Testicular Cancer Study Group

   1. Seidel, Christoph
   2. Oechsle, Karin
   3. Lorch, Anja
   4. Dieing, Annette
   5. Hentrich, Marcus
   6. Hornig, Mareike
   7. Grünwald, Viktor

   2016 - Forschungsinformationssystem des UKE
5. Categories of response to first line vascular endothelial growth factor receptor targeted therapy and overall survival in patients with metastatic renal cell carcinoma

   1. Busch, Jonas
   2. Seidel, Christoph
   3. Goranova, Irena
   4. Erber, Barbara
   5. Peters, Robert
   6. Friedersdorff, Frank
   7. Magheli, Ahmed

   2014 - Forschungsinformationssystem des UKE
6. DNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell cancer (mRCC) treated with antiangiogenic therapies

   1. Peters, Inga
   2. Dubrowinskaja, Natalia
   3. Abbas, Mahmoud
   4. Seidel, Christoph
   5. Kogosov, Michael
   6. Scherer, Ralph
   7. Gebauer, Kai

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
7. A phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC).

   1. Grünwald, Viktor
   2. Desar, Ingrid M E
   3. Haanen, John
   4. Fiedler, Walter
   5. Mouritzen, Ulrik
   6. Olsen, M W Brændholt
   7. Herpen, van

   2011 - Forschungsinformationssystem des UKE
8. Managing side effects of angiogenesis inhibitors in renal cell carcinoma.

   1. Grünwald, Viktor
   2. Heinzer, Hans
   3. Fiedler, Walter

   2007 - Forschungsinformationssystem des UKE